Litigation Details for Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
✉ Email this page to a colleague
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-03-17 |
Court | District Court, D. Delaware | Date Terminated | 2016-06-14 |
Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
Jury Demand | None | Referred To | |
Parties | TEVA PHARMACEUTICAL INDUSTRIES LTD. | ||
Patents | 6,770,623; 6,977,077; 7,144,861; 7,163,684; 7,550,434 | ||
Attorneys | Jack B. Blumenfeld | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Biologic Drugs cited in Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Details for Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-03-17 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,770,623 B1; 7,144,861 B2; 7,550,434…2016 14 June 2016 1:16-cv-00167 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |